Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Showing results (41-50 of 234) with videos related to

Pageof 24
Sort By:
Cancer Treatment and Research|January 1, 1992
Cell motility as an index of metastatic ability in prostate cancers: results with an animal model and with human cancer cellsA W Partin, J L Mohler, D S Coffey
Reviews in Urology|September 21, 2006
Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implicationsS R Potter, J I Epstein, A W Partin
Analytical and Quantitative Cytology and Histology|May 1, 1987
Correlation of prognosis to nuclear roundness and to flow cytometric light scatterJ L Mohler, A W Partin, D S Coffey
The Journal of Urology|July 1, 1987
Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma modelJ L Mohler, A W Partin, D S Coffey
Cancer Research|May 15, 1989
Cancer as a disease of DNA organization and dynamic cell structureK J Pienta, A W Partin, D S Coffey
The Journal of Urology|July 20, 1999
Prostate specific antigen: a decade of discovery--what we have learned and where we are goingT J Polascik, J E Oesterling, A W Partin
Cancer|February 19, 2000
Report on Prostate Cancer Tumor Marker Workshop 1999A W Partin, G P Murphy, M K Brawer
The Journal of Urology|November 1, 1994
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 yearsP C Walsh, A W Partin, J I Epstein
The Journal of Urology|November 1, 1989
Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface chargeH B Carter, A W Partin, D S Coffey
Urology|September 8, 1998
An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 casesG D Carlson, C B Calvanese, A W Partin
Pageof 24

Showing results (41-50 of 234) with videos related to

Sort By:
Pageof 24
Cancer Treatment and Research|January 1, 1992
Cell motility as an index of metastatic ability in prostate cancers: results with an animal model and with human cancer cellsA W Partin, J L Mohler, D S Coffey
Reviews in Urology|September 21, 2006
Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implicationsS R Potter, J I Epstein, A W Partin
Analytical and Quantitative Cytology and Histology|May 1, 1987
Correlation of prognosis to nuclear roundness and to flow cytometric light scatterJ L Mohler, A W Partin, D S Coffey
The Journal of Urology|July 1, 1987
Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma modelJ L Mohler, A W Partin, D S Coffey
Cancer Research|May 15, 1989
Cancer as a disease of DNA organization and dynamic cell structureK J Pienta, A W Partin, D S Coffey
The Journal of Urology|July 20, 1999
Prostate specific antigen: a decade of discovery--what we have learned and where we are goingT J Polascik, J E Oesterling, A W Partin
Cancer|February 19, 2000
Report on Prostate Cancer Tumor Marker Workshop 1999A W Partin, G P Murphy, M K Brawer
The Journal of Urology|November 1, 1994
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 yearsP C Walsh, A W Partin, J I Epstein
The Journal of Urology|November 1, 1989
Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface chargeH B Carter, A W Partin, D S Coffey
Urology|September 8, 1998
An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 casesG D Carlson, C B Calvanese, A W Partin
Pageof 24